<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04957875</url>
  </required_header>
  <id_info>
    <org_study_id>CHESS1905</org_study_id>
    <nct_id>NCT04957875</nct_id>
  </id_info>
  <brief_title>Timing of Endoscopy for Acute Variceal Bleeding in Patients With Cirrhosis</brief_title>
  <official_title>Timing of Endoscopy for Acute Variceal Bleeding in Patients With Cirrhosis (CHESS1905): a Nationwide Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hepatopancreatobiliary Surgery Institute of Gansu Province</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>LanZhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Shijitan Hospital, Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing 302 Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Third Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Sixth People's Hospital of Shenyang</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanxi Bethune Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Linyi People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sir Run Run Shaw Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hepatopancreatobiliary Surgery Institute of Gansu Province</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cirrhotic patients with AVB across 34 university medical centers in 30 cities in China from&#xD;
      February 2013 to May 2020 who underwent endoscopy within 24 hours were included in this&#xD;
      study. Patients were divided into an urgent endoscopy group (endoscopy &lt;6h after admission)&#xD;
      and an early endoscopy group (endoscopy 6-24h after admission). Outcomes included the&#xD;
      incidence of 5-day rebleeding, in-hospital mortality, need for intensive care unit (ICU) and&#xD;
      the length of hospital stay after the endoscopy management. Multivariable analysis was&#xD;
      performed to identify risk factors for rebleeding. A propensity score matching (PSM) analysis&#xD;
      was performed to achieve a balance at baseline between the urgent and early groups.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 16, 2019</start_date>
  <completion_date type="Actual">June 2, 2020</completion_date>
  <primary_completion_date type="Actual">December 16, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the incidence of 5-day rebleeding after emergency endoscopy</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the in-hospital mortality</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>need for ICU</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the length of hospital stay</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">3300</enrollment>
  <condition>Cirrhosis, Liver</condition>
  <condition>Portal Hypertension</condition>
  <condition>Varice Bleed</condition>
  <arm_group>
    <arm_group_label>urgent endoscopy group</arm_group_label>
    <description>endoscopy &lt;6h after admission</description>
  </arm_group>
  <arm_group>
    <arm_group_label>early endoscopy group</arm_group_label>
    <description>endoscopy 6-24h after admission</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>emergency endoscopic therapy</intervention_name>
    <description>When cirrhotic patients presented with AVB to the emergency department, emergency physicians consulted gastroenterologists on duty to assess the patient for suitability for endoscopy, usually after initial stabilization. Performance of endoscopy and its timing was at the discretion of the gastroenterologist on call. Therapeutic endoscopy for AVB was performed within 24 hours after consultation by an experienced attending endoscopist, using standard forward-viewing upper gastrointestinal video endoscopes at individual centers. Written informed consent for endoscopy was obtained before each procedure. The standard of care at all hospitals was to administer a vasoactive agent and antibiotics upon the patient's presentation. Packed red blood cells were transfused at the discretion of the attending gastroenterologist.</description>
    <arm_group_label>early endoscopy group</arm_group_label>
    <arm_group_label>urgent endoscopy group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Complete demographic and clinical data of patients with cirrhosis associated with AVB who&#xD;
        underwent emergency endoscopy within 24 hours between February 2013 and May 2020 across 34&#xD;
        university hospitals from 30 cities in China was retrospectively reviewed. Two independent&#xD;
        investigators (Liu C and Huang Y) reviewed the medical records, including demographic,&#xD;
        laboratory, clinical and endoscopic data.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  established diagnosis of cirrhosis (based on liver biopsy or the combination of&#xD;
             clinical, biochemical, and imaging findings)&#xD;
&#xD;
          -  witnessed or reported evidence of gastrointestinal haemorrhage (hematemesis,&#xD;
             melenemesis, or hematochezia)&#xD;
&#xD;
          -  esophageal or gastric varices confirmed endoscopically as the source of bleeding&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe dysfunction of a major extrahepatic organ (e.g., heart failure, pulmonary&#xD;
             disease, and terminal malignancy except hepatocellular carcinoma)&#xD;
&#xD;
          -  history of endoscopic therapy for varices (ligation or sclerotherapy) within three&#xD;
             months&#xD;
&#xD;
          -  incomplete or missing data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>The first hospital of Lanzhou university</name>
      <address>
        <city>Lanzhou</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018 Aug;69(2):406-460. doi: 10.1016/j.jhep.2018.03.024. Epub 2018 Apr 10. Erratum in: J Hepatol. 2018 Nov;69(5):1207.</citation>
    <PMID>29653741</PMID>
  </reference>
  <reference>
    <citation>Lau JYW, Yu Y, Tang RSY, Chan HCH, Yip HC, Chan SM, Luk SWY, Wong SH, Lau LHS, Lui RN, Chan TT, Mak JWY, Chan FKL, Sung JJY. Timing of Endoscopy for Acute Upper Gastrointestinal Bleeding. N Engl J Med. 2020 Apr 2;382(14):1299-1308. doi: 10.1056/NEJMoa1912484.</citation>
    <PMID>32242355</PMID>
  </reference>
  <reference>
    <citation>Chen PH, Chen WC, Hou MC, Liu TT, Chang CJ, Liao WC, Su CW, Wang HM, Lin HC, Lee FY, Lee SD. Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study. J Hepatol. 2012 Dec;57(6):1207-13. doi: 10.1016/j.jhep.2012.07.038. Epub 2012 Aug 8.</citation>
    <PMID>22885718</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 1, 2021</study_first_submitted>
  <study_first_submitted_qc>July 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2021</study_first_posted>
  <last_update_submitted>July 1, 2021</last_update_submitted>
  <last_update_submitted_qc>July 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hepatopancreatobiliary Surgery Institute of Gansu Province</investigator_affiliation>
    <investigator_full_name>Xiaolong Qi</investigator_full_name>
    <investigator_title>Chief, Institute of Portal Hypertension, The First Hospital of Lanzhou University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Hypertension, Portal</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

